Therapeutic Effects of an Anti-sialyl Lewis X Antibody in a Murine Model of Allergic Asthma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Sep 2021
Historique:
received: 11 08 2021
revised: 02 09 2021
accepted: 13 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 21 10 2021
Statut: epublish

Résumé

Asthma is an allergic disease that causes severe infiltration of leukocytes into the lungs. Leukocyte infiltration is mediated by the binding of sialyl Lewis X (sLe

Identifiants

pubmed: 34576124
pii: ijms22189961
doi: 10.3390/ijms22189961
pmc: PMC8471066
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
P-Selectin 0
Sialyl Lewis X Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : 20ae0101034h0005
Organisme : Japan Society for the Promotion of Science
ID : 20H03379
Organisme : Japan Society for the Promotion of Science
ID : 15K18869

Références

J Clin Invest. 1998 Sep 15;102(6):1132-41
pubmed: 9739047
Pharmacol Ther. 2015 Mar;147:123-135
pubmed: 25448040
Eur Respir J. 2008 Jan;31(1):143-78
pubmed: 18166595
Pharmacol Ther. 2014 Aug;143(2):225-45
pubmed: 24631273
Eur J Immunol. 2005 Jul;35(7):2239-49
pubmed: 15948216
Pulm Pharmacol Ther. 2006;19(4):233-41
pubmed: 16140027
J Appl Physiol (1985). 1997 Feb;82(2):644-51
pubmed: 9049748
Nat Immunol. 2005 Nov;6(11):1096-104
pubmed: 16227985
Blood. 1998 Apr 15;91(8):2847-56
pubmed: 9531595
Adv Drug Deliv Rev. 2004 Mar 3;56(4):527-49
pubmed: 14969757
Curr Protoc Immunol. 2017 Nov 1;119:14.43.1-14.43.22
pubmed: 29091265
J Immunol. 2001 Sep 15;167(6):3146-55
pubmed: 11544300
Adv Immunol. 2018;138:1-34
pubmed: 29731004
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1205-14
pubmed: 10194167
Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019
pubmed: 24343671
Am J Pathol. 2005 Mar;166(3):935-44
pubmed: 15743804
Clin Exp Allergy. 2015 Jan;45(1):54-62
pubmed: 25381695
Cochrane Database Syst Rev. 2017 Sep 21;9:CD010834
pubmed: 28933516
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):645-8; quiz 649
pubmed: 25439351
J Immunol. 2020 Mar 15;204(6):1592-1597
pubmed: 31988179
J Immunol. 2020 Nov 1;205(9):2468-2478
pubmed: 32948685
J Med Chem. 1998 Mar 26;41(7):1099-111
pubmed: 9544210
J Allergy Clin Immunol. 2001 Jun;107(6):1019-24
pubmed: 11398079
Cochrane Database Syst Rev. 2003;(3):CD003559
pubmed: 12917972
Allergol Int. 2021 Apr;70(2):169-173
pubmed: 33637414
Curr Opin Immunol. 2008 Jun;20(3):288-94
pubmed: 18511250
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Immunity. 2001 Jul;15(1):115-26
pubmed: 11485743
J Exp Med. 1996 May 1;183(5):2329-36
pubmed: 8642341
Methods Cell Biol. 2011;103:221-66
pubmed: 21722806
J Exp Med. 1997 Aug 18;186(4):601-12
pubmed: 9254658
Clin Exp Allergy. 2017 Jan;47(1):129-138
pubmed: 27859832
Treat Respir Med. 2005;4(2):85-94
pubmed: 15813660
Front Immunol. 2014 Nov 10;5:570
pubmed: 25426119
Expert Opin Ther Targets. 2014 Jan;18(1):55-67
pubmed: 24074033
Blood. 2000 Nov 15;96(10):3585-91
pubmed: 11071658
Am J Med Sci. 2017 Oct;354(4):339-349
pubmed: 29078837
Clin Exp Allergy. 2008 May;38(5):709-50
pubmed: 18384431
Blood Rev. 2010 Jul-Sep;24(4-5):163-9
pubmed: 20637535
Immunity. 2005 Nov;23(5):479-90
pubmed: 16286016
J Biol Chem. 2015 Jun 12;290(24):15313-26
pubmed: 25944902
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Clin Exp Allergy. 2004 Jan;34(1):77-84
pubmed: 14720266
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18073-8
pubmed: 20923880

Auteurs

Wei Xiong (W)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Wenxin Liu (W)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Shogo Nishida (S)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Daichi Komiyama (D)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Wei Liu (W)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Jotaro Hirakawa (J)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Hiroto Kawashima (H)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH